Return to homepagePandemic Pact

to enable the identification of highly efficacious human anti-SARS-CoV-2 mAbs to protect the most vulnerable populations in low and middle income countries from severe COVID-19

Grant number: INV-019155

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020

  • Known Financial Commitments (USD)

    $2,190,000

  • Funder

    Gates Foundation

  • Research Location

    United States of America

  • Lead Research Institution

    Texas Biomedical Research Institute

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

N/A